PMID: 2496281Apr 1, 1989Paper

Chronic non-A, non-B hepatitis developed after transfusions, illicit self-injections or sporadically. Outcome during long-term follow-up--a comparison

Liver
L MattssonH Glaumann

Abstract

Ninety-two patients with biopsy-proven chronic non-A, non-B hepatitis after blood transfusions, illicit self-injections or sporadically were followed clinically for an average of nearly 5 years. In the posttransfusion hepatitis group, which comprised 37 patients with a mean age of 54 years (range 18-83 years), 59% developed chronic active hepatitis (CAH) and 46% also showed signs of early cirrhosis (eCi) or manifest cirrhosis (Ci). In the illicit self-injection group, comprising 33 patients with a mean age of 26 years (range 17-63 years), 39% manifested CAH and 18% eCi or Ci. In the sporadic group, which consisted of 22 patients with a mean age of 32 years (range 16-62 years), 41% showed CAH and 23% eCi. Thus, in all, 44/92 (48%) of the patients with chronic non-A, non-B hepatitis developed CAH and 28/92 (30%) signs of early or manifest cirrhosis. Patients greater than or equal to 30 years of age displayed CAH and signs of cirrhosis more often than patients less than 30 years of age (p less than 0.01). Chronic non-A, non-B hepatitis is a slowly progressive disease with a high incidence of cirrhosis, especially in patients greater than or equal to 30 years of age and when caused by blood transfusion.

References

Jan 1, 1979·Scandinavian Journal of Infectious Diseases·G NorkransS Iwarson
Apr 26, 1986·Lancet·O WeilandH Glaumann
Feb 1, 1986·Seminars in Liver Disease·J L Dienstag, H J Alter
Mar 1, 1986·American Journal of Clinical Pathology·R D MathiesonM J Alter
Nov 1, 1987·Scandinavian Journal of Gastroenterology·R WejstålG Norkrans
Jan 1, 1980·Scandinavian Journal of Infectious Diseases·P KrygerH Poulsen
Nov 1, 1984·Annals of Internal Medicine·J I WeissbergP B Gregory

❮ Previous
Next ❯

Citations

Jul 1, 1992·Digestive Diseases and Sciences·L el-AshmawyD H Van Thiel
Feb 1, 1992·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·L J JeffersM Houghton
Feb 1, 1991·Annals of Hematology·P BaurD Roelcke
Jan 1, 1993·International Journal of Technology Assessment in Health Care·F FleuretteC Trepo
May 1, 1993·Gastroenterologia Japonica·J M RobertsW G Cooksley
Dec 1, 1996·Digestive Diseases and Sciences·N C Tassopoulos
Jul 1, 1995·Scandinavian Journal of Gastroenterology·R Wejstål
Feb 3, 1998·The American Journal of Gastroenterology·S G ShethS Chopra
Jul 1, 1994·FEMS Microbiology Reviews·O Weiland
Dec 17, 2005·European Journal of Gastroenterology & Hepatology·Blai Dalmau ObradorPere Mas Guiteras

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.